BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16767302)

  • 1. [Insulin resistance/hyperinsulinemia associated diseases not included in the metabolic syndrome].
    Carvalheira JB; Saad MJ
    Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):360-7. PubMed ID: 16767302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.
    Dietrich P; Hellerbrand C
    Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and treatment of metabolic complications in pediatric obesity.
    Ode KL; Frohnert BI; Nathan BM
    Rev Endocr Metab Disord; 2009 Sep; 10(3):167-88. PubMed ID: 19809879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease.
    Baranova A; Tran TP; Birerdinc A; Younossi ZM
    Aliment Pharmacol Ther; 2011 Apr; 33(7):801-14. PubMed ID: 21251033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperinsulinemic syndrome: the metabolic syndrome is broader than you think.
    Kelly CT; Mansoor J; Dohm GL; Chapman WH; Pender JR; Pories WJ
    Surgery; 2014 Aug; 156(2):405-11. PubMed ID: 24962189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of the endocrine system in the pathogenesis of non-alcoholic fatty liver disease].
    Hagymási K; Reismann P; Rácz K; Tulassay Z
    Orv Hetil; 2009 Nov; 150(48):2173-81. PubMed ID: 19923096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome, diabetes, and hyperuricemia.
    Li C; Hsieh MC; Chang SJ
    Curr Opin Rheumatol; 2013 Mar; 25(2):210-6. PubMed ID: 23370374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease and the epidemic of obesity.
    Collantes R; Ong JP; Younossi ZM
    Cleve Clin J Med; 2004 Aug; 71(8):657-64. PubMed ID: 15449761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
    Jeanes YM; Reeves S
    Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease: diagnosis and relation to metabolic syndrome and approach to treatment.
    Lidofsky SD
    Curr Diab Rep; 2008 Feb; 8(1):25-30. PubMed ID: 18366995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction: organ involvement in the cardiometabolic syndrome.
    Hayden MR; Stump CS; Sowers JR
    J Cardiometab Syndr; 2006; 1(1):16-24. PubMed ID: 17675904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should nonalcoholic fatty liver disease be regarded as a hepatic illness only?
    Tarantino G
    World J Gastroenterol; 2007 Sep; 13(35):4669-72. PubMed ID: 17729388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity: epidemiology and clinical aspects.
    Formiguera X; Cantón A
    Best Pract Res Clin Gastroenterol; 2004 Dec; 18(6):1125-46. PubMed ID: 15561643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
    Boppidi H; Daram SR
    Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis of and therapy for nonalcoholic steatohepatitis].
    Onishi S; Saibara T
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1876-80. PubMed ID: 17037330
    [No Abstract]   [Full Text] [Related]  

  • 16. Pediatric obesity and insulin resistance: chronic disease risk and implications for treatment and prevention beyond body weight modification.
    Cruz ML; Shaibi GQ; Weigensberg MJ; Spruijt-Metz D; Ball GD; Goran MI
    Annu Rev Nutr; 2005; 25():435-68. PubMed ID: 16011474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term risks of polycystic ovaries syndrome].
    Lefebvre P; Raingeard I; Renard E; Bringer J
    Gynecol Obstet Fertil; 2004 Mar; 32(3):193-8. PubMed ID: 15123116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of insulin resistance and associated diseases.
    Mlinar B; Marc J; Janez A; Pfeifer M
    Clin Chim Acta; 2007 Jan; 375(1-2):20-35. PubMed ID: 16956601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Syndrome in Polycystic Ovary Syndrome.
    Pasquali R
    Front Horm Res; 2018; 49():114-130. PubMed ID: 29894990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovary syndrome, adipose tissue and metabolic syndrome.
    Delitala AP; Capobianco G; Delitala G; Cherchi PL; Dessole S
    Arch Gynecol Obstet; 2017 Sep; 296(3):405-419. PubMed ID: 28643028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.